Duration of Antibody Responses after Severe Acute Respiratory Syndrome
Top Cited Papers
Open Access
- 1 October 2007
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 13 (10) , 1562-1564
- https://doi.org/10.3201/eid1310.070576
Abstract
Among 176 patients who had had severe acute respiratory syndrome (SARS), SARS-specific antibodies were maintained for an average of 2 years, and significant reduction of immunoglobulin G–positive percentage and titers occurred in the third year. Thus, SARS patients might be susceptible to reinfection >3 years after initial exposure.Keywords
This publication has 14 references indexed in Scilit:
- Two‐Year Prospective Study of the Humoral Immune Response of Patients with Severe Acute Respiratory SyndromeThe Journal of Infectious Diseases, 2006
- Review of Bats and SARSEmerging Infectious Diseases, 2006
- Longitudinal Analysis of Severe Acute Respiratory Syndrome (SARS) Coronavirus-Specific Antibody in SARS PatientsClinical and Vaccine Immunology, 2005
- Bats Are Natural Reservoirs of SARS-Like CoronavirusesScience, 2005
- Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with PseudotypesEmerging Infectious Diseases, 2005
- Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and humanProceedings of the National Academy of Sciences, 2005
- Severe acute respiratory syndromeNature Medicine, 2004
- Neutralizing Antibodies in Patients with Severe Acute Respiratory Syndrome-Associated Coronavirus InfectionThe Journal of Infectious Diseases, 2004
- Longitudinal Profile of Immunoglobulin G (IgG), IgM, and IgA Antibodies against the Severe Acute Respiratory Syndrome (SARS) Coronavirus Nucleocapsid Protein in Patients with Pneumonia Due to the SARS CoronavirusClinical and Vaccine Immunology, 2004
- Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern ChinaScience, 2003